According to the Enterprise Research App, recently, Dongguan Guangzhiyu No. 1 Pharmaceutical Venture Capital Fund partnership was established, with an investment amount of 2 billion yuan. Its business scope includes private equity investment, investment management, and asset management activities. Enterprise investigation and equity penetration showed that the partnership was jointly owned by the Shenzhen Dongyangguang Houdejiangxing Venture Capital Fund Partnership and the Dongguan Industrial Investment Development Parent Fund Partnership.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.